SciSparc (SPRC) Accounts Payables (2016 - 2025)
SciSparc (SPRC) posted Accounts Payables of $783000.0 for Q4 2025, down 3.09% sequentially from $808000.0 in Q2 2025, and down 4.04% YoY from $816000.0 in Q4 2024.
SciSparc (SPRC) Accounts Payables (2016 - 2025) Analysis & Trends
SciSparc has reported Accounts Payables for 10 years, with the latest figure at $783000.0 in Q4 2025.
- Quarterly Accounts Payables fell 4.04% year-over-year to $783000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $783000.0 (down 4.04% YoY) and the FY2025 annual result came in at $783000.0, down 4.04% from the prior year.
- Accounts Payables declined to $783000.0 in Q4 2025 per SPRC's latest filing, from $808000.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $1.2 million in Q2 2023 and troughed at $354000.0 in Q2 2021.
- A 5-year average of $924600.0 and a median of $845000.0 in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2021 and 2022: Accounts Payables plunged 68.05% in 2021, then jumped 146.89% in 2022.
- Over 5 years, Accounts Payables stood at $1.2 million in 2021, then changed by 0.0% to $1.2 million in 2022, then slumped by 33.11% to $802000.0 in 2023, then increased by 1.75% to $816000.0 in 2024, then declined by 4.04% to $783000.0 in 2025.
- According to Business Quant data, Accounts Payables over the past three periods registered $783000.0, $808000.0, and $816000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 35.57 Mn |
| 10 | SciSparc | 807,202.50 | 807,202.50 | - | 783,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 783,000.00 |
| Jun 30, 2025 | 808,000.00 |
| Dec 31, 2024 | 816,000.00 |
| Jun 30, 2024 | 1.16 Mn |
| Dec 31, 2023 | 802,000.00 |
| Jun 30, 2023 | 1.25 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Jun 30, 2022 | 874,000.00 |
| Dec 31, 2021 | 1.20 Mn |
| Jun 30, 2021 | 354,000.00 |
| Dec 31, 2020 | 556,000.00 |
| Jun 30, 2020 | 1.11 Mn |
| Dec 31, 2019 | 864,000.00 |
| Jun 30, 2019 | 885,000.00 |
| Dec 31, 2018 | 1.62 Mn |
| Sep 30, 2018 | 1.29 Mn |
| Jun 30, 2018 | 1.08 Mn |
| Mar 31, 2018 | 1.21 Mn |
| Dec 31, 2017 | 1.02 Mn |
| Sep 30, 2017 | 565,000.00 |